Skip to main content
58°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
December 13, 2021
Tickers
ALXO
Tags
Movers
Market News
Small Cap
From
Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
Tags
Biotech
VIRX
Phase 2 Trial
From
Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers
HARP
Tags
multiple myeloma
Briefs
Movers
From
Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
Tickers
JNJ
LEGN
Tags
Phase 2 Trial
Biotech
Market News
From
Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Tickers
JAZZ
Tags
lymphoma
JAZZ
General
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
Market News
RHHBF
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
gene therapy
ASH21
Phase 1 Trial
From
Benzinga
Merus Shares Updated Data From Zeno Triplet Combo Data In Breast Cancer Settings
December 10, 2021
Tickers
MRUS
Tags
Movers
MRUS
Market News
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
RHHBY
Phase 2 Trial
Biotech
From
Benzinga
Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way
December 10, 2021
Tickers
BNTX
MRNA
SNY
Tags
Biotech
Phase 2 Trial
Influenza Vaccine
From
Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
RHHBF
Market News
From
Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
December 10, 2021
Tickers
ANGN
Tags
Benzinga
General
why it's moving
From
Benzinga
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
December 09, 2021
Tickers
AZN
AZNCF
IPHA
Tags
Movers
Market News
Small Cap
From
Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
December 07, 2021
Tickers
JNJ
Tags
Phase 2 Trial
Biotech
Market News
From
Benzinga
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients
December 07, 2021
Tickers
IDYA
Tags
General
News
Health Care
From
Benzinga
Prometheus Biosciences Posts Phase 1 Data On Lead Therapeutic Candidate
December 07, 2021
Tickers
RXDX
Tags
Phase 1 Trial
Benzinga
General
From
Benzinga
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
December 06, 2021
Tickers
BLCM
Tags
Phase 2 Trial
Biotech
General
From
Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Tickers
OCUL
Tags
Trading Ideas
News
Health Care
From
Benzinga
GH Research Posts Data From Treatment-Resistant Depression Trial
December 06, 2021
Tickers
GHRS
Tags
Earnings
Market News
Biotech
From
Benzinga
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
December 06, 2021
Tickers
BOLT
Tags
Market News
Movers
Briefs
From
Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
December 06, 2021
Tickers
MOLN
Tags
Market News
COVID/19 Coronavirus
Briefs
From
Benzinga
Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome
December 03, 2021
Tickers
STOK
Tags
General
Phase 1 Trial
Benzinga
From
Benzinga
Kazia Unveils Final Data From Mid-Stage Paxalisib Data In Newly Diagnosed Glioblastoma Patients
December 03, 2021
Tickers
KZIA
Tags
General
brain cancer
Brain Tumor
From
Benzinga
Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment
December 03, 2021
Tickers
XENE
Tags
Phase 2 Trial
Biotech
Benzinga
From
Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
December 02, 2021
Tickers
SQZ
Tags
Biotech
Phase 2 Trial
Benzinga
From
Benzinga
ARCA Biopharma Expects Data Readout From Mid-Stage COVID-19 Trial In Q1 2022
December 02, 2021
Tickers
ABIO
Tags
General
Benzinga
Biotech
From
Benzinga
FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease
December 02, 2021
Tickers
CMMB
Tags
Health Care
Trading Ideas
News
From
Benzinga
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
December 02, 2021
Tickers
GSK
VBIV
Tags
Benzinga
brain cancer
General
From
Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
December 02, 2021
Tickers
INBX
Tags
General
Phase 1 Trial
Benzinga
From
Benzinga
Clene's Amyotrophic Lateral Sclerosis Candidate Shows Favorable Impact On Disease Progression
December 01, 2021
Tickers
CLNN
Tags
General
Benzinga
CLNN
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.